Sasaki Yosuke, Shimizu Hiroshige, Nemoto Tetsuo, Urita Yoshihisa
Department of General Medicine and Emergency Care, Toho University, School of Medicine, Tokyo, Japan.
Department of General Medicine and Emergency Care, Toho University, School of Medicine, Tokyo, Japan Department of Respiratory Medicine, Toho University, School of Medicine, Tokyo, Japan.
BMJ Case Rep. 2016 Apr 21;2016:bcr2016215047. doi: 10.1136/bcr-2016-215047.
The strong association between myositis and malignancy has been well recognised. Cancer-associated myositis (CAM) is thought to be a cross-reaction to regenerating muscle tissue similar to tumour antigen. We report a case of CAM due to oesophageal adenocarcinoma arising in Barrett's oesophagus without elevation of myogenic enzymes, diagnosed by MRI and repeated endoscopy. Elderly onset, prominent symptoms, lack of interstitial pneumonia, poorer response to immunosuppressive therapies, and the combination of negative conventional myositis-related antibodies and positive anti-p155/140 antibody may help to distinguish CAM from idiopathic inflammatory myopathy. As the prognosis of patients with CAM depends on the malignancy, aggressive diagnosis of CAM and the causative malignancy is required. Our experience underscores the importance of avoiding the over-reliance on serum myogenic enzymes for excluding CAM and recognising MRI as a useful diagnostic tool of myositis.
肌炎与恶性肿瘤之间的强关联已得到充分认识。癌症相关肌炎(CAM)被认为是对类似于肿瘤抗原的再生肌肉组织的交叉反应。我们报告一例由巴雷特食管发生的食管腺癌引起的CAM病例,该病例无肌源性酶升高,通过MRI和重复内镜检查确诊。老年发病、突出症状、无间质性肺炎、对免疫抑制治疗反应较差,以及传统肌炎相关抗体阴性和抗p155/140抗体阳性的组合可能有助于将CAM与特发性炎性肌病区分开来。由于CAM患者的预后取决于恶性肿瘤,因此需要对CAM和致病恶性肿瘤进行积极诊断。我们的经验强调了避免过度依赖血清肌源性酶来排除CAM以及认识到MRI作为肌炎有用诊断工具的重要性。